|
1
|
Ferlay J, Colombet M, Soerjomataram I,
Mathers C, Parkin DM, Piñeros M, Znaor A and Bray F: Estimating the
global cancer incidence and mortality in 2018: GLOBOCAN sources and
methods. Int J Cancer. 144:1941–1953. 2019. View Article : Google Scholar
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Feng RM, Zong YN, Cao SM and Xu RH:
Current cancer situation in China: Good or bad news from the 2018
global cancer statistics? Cancer Commun (Lond). 39:222019.
View Article : Google Scholar
|
|
4
|
de la Mare JA, Contu L, Hunter MC, Moyo B,
Sterrenberg JN, Dhanani KC, Mutsvunguma LZ and Edkins AL: Breast
cancer: Current developments in molecular approaches to diagnosis
and treatment. Recent Pat Anticancer Drug Discov. 9:153–175. 2014.
View Article : Google Scholar
|
|
5
|
Shi X, Sun M, Liu H, Yao Y and Song Y:
Long non-coding RNAs: A new frontier in the study of human
diseases. Cancer Lett. 339:159–166. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tsai MC, Spitale RC and Chang HY: Long
intergenic noncoding RNAs: New links in cancer progression. Cancer
Res. 71:3–7. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen X, Dai M, Zhu H, Li J, Huang Z, Liu
X, Huang Y, Chen J and Dai S: Evaluation on the diagnostic and
prognostic values of long non-coding RNA BLACAT1 in common types of
human cancer. Mol Cancer. 16:1602017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dai M, Chen X, Mo S, Li J, Huang Z, Huang
S, Xu J, He B, Zou Y, Chen J and Dai S: Meta-signature LncRNAs
serve as novel biomarkers for colorectal cancer: Integrated
bioinformatics analysis, experimental validation and diagnostic
evaluation. Sci Rep. 7:465722017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ye JR, Liu L and Zheng N: Long noncoding
RNA bladder cancer associated transcript 1 promotes the
proliferation, migration, and invasion of nonsmall cell lung cancer
through sponging miR-144. DNA Cell Biol. 36:845–852. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rinn JL, Kertesz M, Wang JK, Squazzo SL,
Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E and
Chang HY: Functional demarcation of active and silent chromatin
domains in human HOX loci by noncoding RNAs. Cell. 129:1311–1323.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bhan A, Soleimani M and Mandal SS: Long
noncoding RNA and cancer: A new paradigm. Cancer Res. 77:3965–3981.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huang HW, Xie H, Ma X, Zhao F and Gao Y:
Upregulation of LncRNA PANDAR predicts poor prognosis and promotes
cell proliferation in cervical cancer. Eur Rev Med Pharmacol Sci.
21:4529–4535. 2017.PubMed/NCBI
|
|
13
|
Zang W, Wang T, Huang J, Li M, Wang Y, Du
Y, Chen X and Zhao G: Long noncoding RNA PEG10 regulates
proliferation and invasion of esophageal cancer cells. Cancer Gene
Ther. 22:138–144. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ding X, Zhang S, Li X, Feng C, Huang Q,
Wang S, Wang S, Xia W, Yang F, Yin R, et al: Profiling expression
of coding genes, long noncoding RNA, and circular RNA in lung
adenocarcinoma by ribosomal RNA-depleted RNA sequencing. FEBS Open
Bio. 8:544–555. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hu X, Liu Y, Du Y, Cheng T and Xia W: Long
non-coding RNA BLACAT1 promotes breast cancer cell proliferation
and metastasis by miR-150-5p/CCR2. Cell Biosci. 9:142019.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jia YC, Wang JY, Liu YY, Li B, Guo H and
Zang AM: LncRNA MAFG-AS1 facilitates the migration and invasion of
NSCLC cell via sponging miR-339-5p from MMP15. Cell Biol Int.
43:384–393. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cui S, Yang X, Zhang L, Zhao Y and Yan W:
LncRNA MAFG-AS1 promotes the progression of colorectal cancer by
sponging miR-147b and activation of NDUFA4. Biochem Biophys Res
Commun. 506:251–258. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li H, Zhang GY, Pan CH, Zhang XY and Su
XY: LncRNA MAFG-AS1 promotes the aggressiveness of breast carcinoma
through regulating miR-339-5p/MMP15. Eur Rev Med Pharmacol Sci.
23:2838–2846. 2019.PubMed/NCBI
|
|
19
|
Wang JS, Liu QH, Cheng XH, Zhang WY and
Jin YC: The long noncoding RNA ZFAS1 facilitates bladder cancer
tumorigenesis by sponging miR-329. Biomed Pharmacother.
103:174–181. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lu S, Sun Z, Tang L and Chen L: LINC00355
promotes tumor progression in HNSCC by hindering
MicroRNA-195-mediated suppression of HOXA10 expression. Mol Ther
Nucleic Acids. 19:61–71. 2020. View Article : Google Scholar
|
|
21
|
Xiao H: MiR-7-5p suppresses tumor
metastasis of non-small cell lung cancer by targeting NOVA2. Cell
Mol Biol Lett. 24:602019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang Q, Zheng J and Liu L: The long
noncoding RNA PCGEM1 promotes cell proliferation, migration and
invasion via targeting the miR-182/FBXW11 axis in cervical cancer.
Cancer Cell Int. 19:3042019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen X, Xu X, Pan B, Zeng K, Xu M, Liu X,
He B, Pan Y, Sun H and Wang S: miR-150-5p suppresses tumor
progression by targeting VEGFA in colorectal cancer. Aging (Albany
NY). 10:3421–3437. 2018. View Article : Google Scholar
|
|
24
|
Lu W, Zhang H, Niu Y, Wu Y, Sun W, Li H,
Kong J, Ding K, Shen HM, Wu H, et al: Long non-coding RNA linc00673
regulated non-small cell lung cancer proliferation, migration,
invasion and epithelial mesenchymal transition by sponging
miR-150-5p. Mol Cancer. 16:1182017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sakr M, Takino T, Sabit H, Nakada M, Li Z
and Sato H: miR-150-5p and miR-133a suppress glioma cell
proliferation and migration through targeting membrane-type-1
matrix metallo-proteinase. Gene. 587:155–162. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Edge SB and Compton CC: The American joint
committee on cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
28
|
Li JH, Liu S, Zhou H, Qu LH and Yang JH:
starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA
interaction networks from large-scale CLIP-Seq data. Nucleic Acids
Res. 42:D92–D97. 2014. View Article : Google Scholar
|
|
29
|
Sen R, Ghosal S, Das S, Balti S and
Chakrabarti J: Competing endogenous RNA: The key to
posttranscriptional regulation. ScientificWorldJournal.
2014:8962062014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tay Y, Rinn J and Pandolfi PP: The
multilayered complexity of ceRNA crosstalk and competition. Nature.
505:344–352. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Khatib A, Solaimuthu B, Yosef MB, Rmaileh
AA, Tanna M, Oren G, Frisch MS, Axelrod JH, Lichtenstein M and
Shaul YD: The glutathione peroxidase 8 (GPX8)/IL-6/STAT3 axis is
essential in maintaining an aggressive breast cancer phenotype.
Proc Natl Acad Sci USA. 117:21420–21431. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cataldo A, Romero-Cordoba S, Plantamura I,
Cosentino G, Hidalgo-Miranda A, Tagliabue E and Iorio MV: MiR-302b
as a combinatorial therapeutic approach to improve cisplatin
chemotherapy efficacy in human triple-negative breast cancer.
Cancers (Basel). 12:22612020. View Article : Google Scholar
|
|
33
|
Naik SK, Lam EWF, Parija M, Prakash S,
Jiramongkol Y, Adhya AK, Parida DK and Mishra SK: NEDDylation
negatively regulates ERRβ expression to promote breast cancer
tumorigenesis and progression. Cell Death Dis. 11:7032020.
View Article : Google Scholar
|
|
34
|
Rodríguez Bautista R, Ortega Gómez A,
Hidalgo Miranda A, Zentella Dehesa A, Villarreal-Garza C,
Ávila-Moreno F and Arrieta O: Long non-coding RNAs: Implications in
targeted diagnoses, prognosis, and improved therapeutic strategies
in human non- and triple-negative breast cancer. Clin Epigenetics.
10:882018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Dong H, Wang W, Mo S, Liu Q, Chen X, Chen
R, Zhang Y, Zou K, Ye M, He X, et al: Long non-coding RNA SNHG14
induces trastuzumab resistance of breast cancer via regulating
PABPC1 expression through H3K27 acetylation. J Cell Mol Med.
22:4935–4947. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu M, Gou L, Xia J, Wan Q, Jiang Y, Sun
S, Tang M, He T and Zhang Y: LncRNA ITGB2-AS1 could promote the
migration and invasion of breast cancer cells through up-regulating
ITGB2. Int J Mol Sci. 19:18662018. View Article : Google Scholar :
|
|
37
|
Gu J, Wang Y, Wang X, Zhou D, Wang X, Zhou
M and He Z: Effect of the LncRNA GAS5-MiR-23a-ATG3 axis in
regulating autophagy in patients with breast cancer. Cell Physiol
Biochem. 48:194–207. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yang F, Shen Y, Zhang W, Jin J, Huang D,
Fang H, Ji W, Shi Y, Tang L, Chen W, et al: An androgen receptor
negatively induced long non-coding RNA ARNILA binding to miR-204
promotes the invasion and metastasis of triple-negative breast
cancer. Cell Death Differ. 25:2209–2220. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Schwarzenbacher D, Klec C, Pasculli B,
Cerk S, Rinner B, Karbiener M, Ivan C, Barbano R, Ling H,
Wulf-Goldenberg A, et al: MiR-1287-5p inhibits triple negative
breast cancer growth by interaction with phosphoinositide 3-kinase
CB, thereby sensitizing cells for PI3Kinase inhibitors. Breast
Cancer Res. 21:202019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li S, Xu JJ and Zhang QY: MicroRNA-132-3p
inhibits tumor malignant progression by regulating
lysosomal-associated protein transmembrane 4 beta in breast cancer.
Cancer Sci. 110:3098–3109. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Rettig EM, Tan M, Ling S, Yonescu R,
Bishop JA, Fakhry C and Ha PK: MYB rearrangement and
clinicopathologic characteristics in head and neck adenoid cystic
carcinoma. Laryngoscope. 125:E292–E299. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
West RB, Kong C, Clarke N, Gilks T,
Lipsick JS, Cao H, Kwok S, Montgomery KD, Varma S and Le QT: MYB
expression and translocation in adenoid cystic carcinomas and other
salivary gland tumors with clinicopathologic correlation. Am J Surg
Pathol. 35:92–99. 2011. View Article : Google Scholar :
|
|
43
|
Andersson MK, Afshari MK, Andrén Y, Wick
MJ and Stenman G: Targeting the oncogenic transcriptional regulator
MYB in adenoid cystic carcinoma by inhibition of IGF1R/AKT
signaling. J Natl Cancer Inst. 109:2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Mitra P: Transcription regulation of MYB:
A potential and novel therapeutic target in cancer. Ann Transl Med.
6:4432018. View Article : Google Scholar :
|
